ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
N/A | ||
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
one-third of one redeemable warrant |
||||
Auditor Firm ID: |
Auditor Name: |
Auditor Location: |
Large accelerated filer |
☐ |
Accelerated filer |
☐ | |||
☒ |
Smaller reporting company |
|||||
Emerging growth company |
3 |
||||||
3 |
||||||
22 |
||||||
57 |
||||||
58 |
||||||
58 |
||||||
58 |
||||||
59 |
||||||
59 |
||||||
59 |
||||||
59 |
||||||
63 |
||||||
63 |
||||||
63 |
||||||
63 |
||||||
64 |
||||||
65 |
||||||
65 |
||||||
70 |
||||||
71 |
||||||
72 |
||||||
74 |
||||||
76 |
||||||
76 |
||||||
78 |
||||||
79 |
• | our ability to select an appropriate target business or businesses; |
• | our ability to complete our initial business combination; |
• | our expectations around the performance of the prospective target business or businesses; |
• | our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; |
• | our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination; |
• | our potential ability to obtain additional financing to complete our initial business combination; |
• | our pool of prospective target businesses; |
• | our ability to consummate an initial business combination due to the continuing uncertainty resulting from the COVID-19 pandemic; |
• | the ability of our officers and directors to generate a number of potential business combination opportunities; |
• | our public securities’ liquidity and trading; |
• | the use of proceeds not held in the trust account or available to us from interest income on the trust account balance; |
• | the trust account not being subject to claims of third parties; |
• | our financial performance; or |
• | the lack of a market for our securities. |
• | We are a blank check company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective. |
• | Our public shareholders may not be afforded an opportunity to vote on our proposed business combination, and your only opportunity to affect the investment decision regarding a potential business combination may be limited to the exercise of your right to redeem your shares from us for cash. |
• | Certain requirements and terms of our securities may make it difficult for us to enter into our initial business combination with a target or may not allow us to consummate the most desirable business combination or optimize our capital structure. |
• | Our search for a business combination may be materially adversely affected by the coronavirus (COVID-19) pandemic and the status of debt and equity markets. |
• | Holders of warrants will not participate in liquidating distributions if we do not complete an initial business combination within the required time period, and the warrants will expire worthless. |
• | We may not be able to consummate our initial business combination within the required time period, in which case we would cease all operations except for the purpose of winding up and we would redeem our public shares and liquidate. |
• | Our initial shareholders control the election of our board of directors until consummation of our initial business combination and hold a substantial interest in our common stock. As a result, they will exert a substantial influence on actions requiring a shareholder vote, potentially in a manner that you do not support. |
• | You will not have any rights or interests in funds from the trust account, except under certain circumstances. To liquidate your investment, therefore, you may be forced to sell your public shares, potentially at a loss. |
• | If third parties bring claims against us or in certain other circumstances, such as a bankruptcy, the proceeds held in the trust account could be reduced and the per share redemption amount received by shareholders may be less than $10.00 per share. |
• | We may issue additional Class A ordinary shares or preferred shares or incur substantial debt in connection with our initial business combination, which could dilute your interests, adversely affect our financial condition and thus negatively impact the value of our shareholders’ investment in us. |
• | We cannot assure you that we will not seek to amend our amended and restated certificate of incorporation or governing instruments, including our warrant agreement, in a manner that will make it easier for us to complete our initial business combination that some of our shareholders or warrant holders may not support. |
• | Past performance by our management team on whom we are dependent may not be indicative of future performance of an investment in us or in the future performance of any business we may acquire. |
• | We have identified a material weakness in our internal control over financial reporting. If we are unable to develop and maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results in a timely manner, which may adversely affect investor confidence in us and materially and adversely affect our business and operating results. |
• | Members of our management team and their respective affiliates may have conflicts of interests that could, as applicable, affect the amount of time allocated to our company, impact the business opportunities presented to us, or raise competitive financial interests or affiliations with one or more of target businesses. |
• | Management’s flexibility in identifying and selecting a prospective acquisition target, along with our management’s financial interest in consummating our initial business combination, may lead management to enter into an acquisition agreement that is not in the best interest of our shareholders. |
• | We face certain risks if we acquire or operate a business outside of the United States, including social disturbances and military actions in regions where such business might be located. |
• | There is currently no market for our securities and a market for our securities may not develop, which would adversely affect the liquidity and price of our securities. |
• | We may redeem unexpired warrants prior to their exercise at a time that is disadvantageous to holders. |
• | The other risks and uncertainties discussed in Part I, Item 1A., “Risk Factors” and elsewhere in this Annual Report on Form 10-K. |
ITEM 1. |
BUSINESS. |
• | identifying best-in-class |
• | conducting deep-level due diligence on business combination targets and developing an efficient, targeted process to evaluate target companies; |
• | identifying value-creating corporate development and strategic initiatives and operational efficiencies that can be realized by potential target companies; and |
• | providing strategic insight with respect to negotiations with targets, drawing on their experience with structuring mergers, acquisitions, joint ventures and partnerships. |
• | enterprise value in excess of $750 million; |
• | developed differentiated products or services with strong unit economics and that have achieved high growth and have significant continued growth opportunities, including further market expansion; |
• | incremental upside potential, which we could access with our unique operational expertise, industry relationships and access to capital; |
• | products that have already reached a level of maturity and have a leading or niche market position that demonstrates competitive advantage and can create sustainable barriers to entry against new competitors; |
• | a large total addressable market and diversified revenue streams, with opportunity for further expansion across products, verticals or target segments; |
• | consistent organic revenue growth with scalable unit economics and potential for further margin expansion; |
• | a strong, experienced management team that could benefit from our management team’s additional support, insights and network; |
• | founders with a long-term vision for their company; |
• | a global presence or potential global presence that will resonate with U.S. investors; |
• | sectors where management can benefit from our extensive networks and insights; |
• | the capability to operate as a public company, including a strong management team, appropriate corporate governance and reporting policies and capabilities; and |
• | attractive value relative to the target’s existing cash flows, potential for operational improvement and the opportunity for long-term value creation in public markets. |
• | subject us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which we operate after our initial business combination; and |
• | cause us to depend on the marketing and sale of a single product or limited number of products or services. |
• | We issue ordinary shares that will be equal to or in excess of 20% of the number of our ordinary shares then issued and outstanding (other than in a public offering); |
• | Any of our directors, officers or substantial shareholders (as defined by Nasdaq rules) has a 5% or greater interest (or such persons collectively have a 10% or greater interest), directly or indirectly, in the target business or assets to be acquired or otherwise and the present or potential issuance of ordinary shares could result in an increase in outstanding ordinary shares or voting power of 5% or more; or |
• | The issuance or potential issuance of ordinary shares will result in our undergoing a change of control. |
• | conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A under the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules; and |
• | file proxy materials with the SEC. |
• | conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E under the Exchange Act, which regulate issuer tender offers, and |
• | file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about the initial business combination and the redemption rights as is required under Regulation 14A under the Exchange Act, which regulates the solicitation of proxies. |
ITEM 1A. |
RISK FACTORS. |
• | a limited availability of market quotations for our securities; |
• | reduced liquidity for our securities; |
• | a determination that our Class A ordinary shares are a “penny stock,” which will require brokers trading in our Class A ordinary shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; |
• | a limited amount of news and analyst coverage; and |
• | decreased ability to issue additional securities or obtain additional financing in the future. |
• | restrictions on the nature of our investments; and |
• | restrictions on the issuance of securities, |
• | registration as an investment company; |
• | adoption of a specific form of corporate structure; and |
• | reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations. |
• | may significantly dilute the equity interest of our public shareholders; |
• | may subordinate the rights of holders of Class A ordinary shares if preference shares are issued with rights senior to those afforded our Class A ordinary shares; |
• | could cause a change in control if a substantial number of Class A ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; and |
• | may adversely affect prevailing market prices for our units, Class A ordinary shares and/or warrants. |
• | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
• | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
• | our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand; |
• | our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding; |
• | our inability to pay dividends on our Class A ordinary shares; |
• | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A ordinary shares if declared, expenses, capital expenditures, acquisitions and other general corporate purposes; |
• | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
• | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and |
• | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt. |
• | solely dependent upon the performance of a single business, property or asset; or |
• | dependent upon the development or market acceptance of a single or limited number of products, processes or services. |
• | inability to compete effectively in a highly competitive environment with many incumbents having substantially greater resources; |
• | inability to manage rapid change, increasing consumer expectations and growth; |
• | inability to build strong brand identity and improve subscriber or customer satisfaction and loyalty; |
• | reliance on proprietary technology to provide services and to manage our operations, and the failure of this technology to operate effectively, or our failure to use such technology effectively; |
• | inability to deal with our subscribers’ or customers’ privacy concerns; |
• | inability to attract and retain subscribers or customers; |
• | inability to license or enforce intellectual property rights on which our business may depend; |
• | any significant disruption in our computer systems or those of third parties that we would utilize in our operations; |
• | inability by us, or a refusal by third parties, to license content to us upon acceptable terms; |
• | potential liability for negligence, copyright or trademark infringement or other claims based on the nature and content of materials that we may distribute; |
• | competition for advertising revenue; |
• | competition for the leisure and entertainment time and discretionary spending of subscribers or customers, which may intensify in part due to advances in technology and changes in consumer expectations and behavior; |
• | disruption or failure of our networks, systems or technology as a result of computer viruses, “cyberattacks,” misappropriation of data or other malfeasance, as well as outages, natural disasters, terrorist attacks, accidental releases of information or similar events; |
• | inability to obtain necessary hardware, software and operational support; and |
• | reliance on third-party vendors or service providers. |
Public shares |
34,500,000 | |||
Founder shares |
8,625,000 | |||
|
|
|||
Total shares |
43,125,000 | |||
Total funds in trust available for initial business combination (1) |
$ | 345,017,891 | ||
Implied value per share |
$ | 8.00 | ||
Public shareholders’ investment per share (2) |
$ | 10.00 | ||
Sponsor’s investment per share (3) |
$ | 0.003 |
(1) | Funds held in trust account as of December 31, 2021. Does not take into account other potential impacts on our valuation at the time of the business combination, such as the value of our public and private warrants, the trading price of our public shares, the business combination transaction costs (including payment of $9,450,000 of deferred underwriting commissions), any equity issued or cash paid to the business target’s sellers or other third parties, or the target’s business itself, including its assets, liabilities, management and prospects. |
(2) | While the public shareholders’ investment is in both the public shares and the public warrants, for purposes of this table no value is ascribed to the public warrants. |
(3) | Represents the per share price paid by our sponsor for the founder shares. The sponsor’s total investment in us is equal to approximately $7,650,000, which includes the payment of $25,000 for the founder shares and the payment by our sponsor of approximately $7,625,000 for the private placement warrants. |
• | costs and difficulties inherent in managing cross-border business operations and complying with commercial and legal requirements of overseas markets; |
• | rules and regulations regarding currency redemption; |
• | complex corporate withholding taxes on individuals; |
• | laws governing the manner in which future business combinations may be effected; |
• | exchange listing and/or delisting requirements; |
• | tariffs and trade barriers; |
• | regulations related to customs and import/export matters; |
• | local or regional economic policies and market conditions; |
• | unexpected changes in regulatory requirements; |
• | challenges in managing and staffing international operations; |
• | longer payment cycles; |
• | tax issues, such as tax law changes and variations in tax laws as compared to the United States; |
• | currency fluctuations and exchange controls; |
• | rates of inflation, price instability and interest rate fluctuations; |
• | liquidity of domestic capital and lending markets; |
• | challenges in collecting accounts receivable; |
• | cultural and language differences; |
• | employment regulations; |
• | underdeveloped or unpredictable legal or regulatory systems; |
• | corruption; |
• | protection of intellectual property; |
• | social unrest, natural disasters, crime, strikes, riots and civil disturbances; |
• | epidemics and pandemics; |
• | regime changes and political upheaval; |
• | Different reporting requirements; |
• | terrorist attacks and wars; and |
• | deterioration of political relations with the United States. |
• | we have a board that includes a majority of “independent directors,” as defined under the rules of Nasdaq; |
• | we have a compensation committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities; and |
• | we have a nominating and corporate governance committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities. |
ITEM 1B. |
UNRESOLVED STAFF COMMENTS. |
ITEM 2. |
PROPERTIES. |
ITEM 3. |
LEGAL PROCEEDINGS. |
ITEM 4. |
MINE SAFETY DISCLOSURES |
ITEM 5. |
MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES. |
ITEM 6. |
SELECTED FINANCIAL DATA. |
ITEM 7. |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. |
ITEM 7A. |
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK. |
ITEM 8. |
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA. |
ITEM 9. |
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE. |
ITEM 9A. |
CONTROLS AND PROCEDURES. |
ITEM 9B. |
OTHER INFORMATION. |
ITEM 10. |
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE. |
Name |
Age |
Position | ||
Dominik Richter | 37 | Chairman, Director | ||
Roman Kirsch | 34 | Chief Executive Officer, Director | ||
Spyro Korsanos | 49 | Chief Financial Officer | ||
Manuel Stotz | 38 | Director | ||
Jonathan Teklu | 35 | Director | ||
Jeronimo Folgueira | 40 | Director |
• | assisting board oversight of (1) the integrity of our financial statements, (2) our compliance with legal and regulatory requirements, (3) our independent registered public accounting firm’s qualifications and independence, and (4) the performance of our internal audit function and independent auditors; the appointment, compensation, retention, replacement, and oversight of the work of the independent auditors and any other independent registered public accounting firm engaged by us; |
• | pre-approving all audit and non-audit services to be provided by the independent auditors or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures; reviewing and discussing with the independent auditors all relationships the auditors have with us in order to evaluate their continued independence; |
• | setting clear policies for audit partner rotation in compliance with applicable laws and regulations; obtaining and reviewing a report, at least annually, from the independent registered public accounting firm describing (1) the independent auditor’s internal quality-control procedures and (2) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities, within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues; |
• | meeting to review and discuss our annual audited financial statements and quarterly financial statements with management and the independent auditor, including reviewing our specific disclosures under “Management’s Discussion and Analysis of Financial Condition and Results of Operations”; reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and |
• | reviewing with management, the independent auditors, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities. |
• | reviewing and approving on an annual basis the corporate goals and objectives relevant to our chief executive officer’s compensation, evaluating our chief executive officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our chief executive officer based on such evaluation; |
• | reviewing and making recommendations to our board of directors with respect to the compensation, and any incentive compensation and equity based plans that are subject to board approval of all of our other officers; |
• | reviewing our executive compensation policies and plans; |
• | implementing and administering our incentive compensation equity-based remuneration plans; |
• | assisting management in complying with our proxy statement and annual report disclosure requirements; |
• | approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our officers and employees; |
• | producing a report on executive compensation to be included in our annual proxy statement; and |
• | reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. |
• | identifying, screening and reviewing individuals qualified to serve as directors, consistent with criteria approved by the board, and recommending to the board of directors candidates for nomination for appointment at the annual general meeting or to fill vacancies on the board of directors; |
• | developing and recommending to the board of directors and overseeing implementation of our corporate governance guidelines; |
• | coordinating and overseeing the annual self-evaluation of the board of directors, its committees, individual directors and management in the governance of the company; and |
• | reviewing on a regular basis our overall corporate governance and recommending improvements as and when necessary. |
ITEM 11. |
EXECUTIVE COMPENSATION. |
ITEM 12. |
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS. |
• | each person known by us to be the beneficial owner of more than 5% of our issued and outstanding ordinary shares; |
• | each of our officers and directors; and |
• | all our officers and directors as a group. |
Name and Address of Beneficial Owner(1) |
Number of Shares Beneficially Owned |
Approximate Percentage of Outstanding Ordinary Shares |
||||||
Tio Tech SPAC Holdings GmbH(3) |
8,625,000 | (2) | 20.0 | % | ||||
Ari Zweiman(4) |
2,000,000 | 5.8 | % | |||||
Ravi Mehta(5) |
2,000,000 | 5.8 | % | |||||
Dominik Richter |
— | — | ||||||
Roman Kirsch |
— | — | ||||||
Spyro Korsanos |
— | — | ||||||
Manuel Stotz |
— | — | ||||||
Jonathan Teklu |
— | — | ||||||
Jeronimo Folgueira |
— | — | ||||||
All officers and directors as a group (6 individuals) |
— | — |
* | Less than one percent. |
(1) | Unless otherwise noted, the business address of each of the following is c/o Tio Tech SPAC Holdings GmbH, Unter den Linden 21, 10117 Berlin, Germany. |
(2) | Interests shown consist solely of founder shares, classified as Class B ordinary shares. As described in our registration statement on Form S-1 (File No. 333-253369), the Class B ordinary shares will automatically convert into Class A ordinary shares at the time of our initial business combination on a one-for-one |
(3) | Tio Tech SPAC Holdings GmbH is the record holder of the shares reported herein. The three managing directors of Tio Tech SPAC Holdings GmbH are Dominik Richter, Roman Kirsch and Spyro Korsanos. Under the so-called “rule of three,” if voting and dispositive decisions regarding an entity’s securities are made by two or more individuals, and a voting and dispositive decision requires the approval of a majority of those individuals, then none of the individuals is deemed a beneficial owner of the entity’s securities. Therefore, none of Messrs. Richter, Kirsch or Korsanos exercises voting or dispositive control over any of the securities held by the Sponsor, even those in which he holds any direct or indirect pecuniary interest. Accordingly, none of Messrs. Richter, Kirsch or Korsanos is deemed to have or share beneficial ownership of the founder shares held by Tio Tech SPAC Holdings GmbH. |
(4) | 683 Capital Partners, LP is the record holder of the shares reported herein. 683 Capital Management, LLC is the investment manager of 683 Capital Partners, LP. Mr. Zweiman is the managing member of 683 Capital Management, LLC and thus is deemed to beneficially own the shares held by 683 Capital Partners, LP. The business address for Mr. Zweiman is 3 Columbus Circle, Suite 2205, New York, NY 10019. |
(5) | Steadview Capital Management LLC is the record holder of the shares reported herein. Mr. Mehta serves as Managing Director of Steadview Capital Management LLC and thus is deemed to beneficially own the shares held by Steadview Capital Management LLC. The business address for Mr. Mehta is 30 Berkeley Square, 6th Floor, London, United Kingdom, W1J 6EX. |
ITEM 13. |
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE. |
ITEM 14. |
PRINCIPAL ACCOUNTING FEES AND SERVICES. |
ITEM 15. |
EXHIBITS AND FINANCIAL STATEMENT SCHEDULES. |
F-2 |
||||
Financial Statements: |
||||
F-3 |
||||
F-4 |
||||
F-5 |
||||
F-6 |
||||
F-7 to F-20 |
* | Filed herewith. |
** | Furnished herewith |
(1) | Previously filed as an exhibit to our Current Report on Form 8-K filed on April 12, 2021 (File No. 001-40317) and incorporated by reference herein. |
ITEM 16. |
FORM 10-K SUMMARY. |
F-2 |
||||
Financial Statements: |
||||
F-3 |
||||
F-4 |
||||
F-5 |
||||
F-6 |
||||
F-7 to F-20 |
Assets |
||||
Current Assets: |
||||
Cash |
$ | |||
Prepaid expenses |
||||
|
|
|||
Total current assets |
||||
Prepaid expenses - non-current |
||||
Investments held in Trust Account |
||||
|
|
|||
Total assets |
$ | |||
|
|
|||
Liabilities, Class A ordinary shares subject to possible redemption and Shareholders’ Deficit |
||||
Current liabilities: |
||||
Accounts payable and accrued expenses |
$ | |||
Due to related party |
||||
|
|
|||
Total current liabilities |
||||
Warrant liabilities |
||||
Deferred Underwriters’ discount |
||||
|
|
|||
Total liabilities |
||||
|
|
|||
Commitments and contingencies |
||||
Class A ordinary shares subject to possible redemption, |
||||
Shareholders’ Deficit: |
||||
Preference shares, $ |
||||
Class A ordinary shares, $ |
||||
Class B ordinary shares, $ |
||||
Additional paid-in capital |
||||
Accumulated deficit |
( |
) | ||
|
|
|||
Total shareholders’ deficit |
( |
) | ||
|
|
|||
Total Liabilities, Class A ordinary shares subject to possible redemption and Shareholders’ Deficit |
$ | |||
|
|
|||
Formation and operating costs |
$ | |||
|
|
|||
Loss from operations |
( |
) | ||
Other income (expense) |
||||
Income on marketable securities held in trust |
||||
Change in fair value of warrant liabilities |
||||
Offering cost allocated to warrants |
( |
) | ||
|
|
|||
Total other income |
||||
|
|
|||
Net income |
$ | |||
|
|
|||
Weighted average Class A ordinary shares subject to possible redemption outstanding, basic and diluted |
||||
|
|
|||
Basic and diluted net income per ordinary share subject to possible redemption |
$ | |||
|
|
|||
Weighted average non-redeemable Class A and Class B ordinary shares outstanding |
||||
|
|
|||
Basic and diluted net income per non-redeemable ordinary share |
$ | |||
|
|
Ordinary Shares |
Additional Paid-In Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
|||||||||||||||||||||||||
Class A |
Class B |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance as of February 8, 2021 (Inception) |
$ | $ | $ | $ | $ | |||||||||||||||||||||||
Issuance of Founder shares on February 10, 2021 |
— | — | — | |||||||||||||||||||||||||
Excess cash received on sale of |
— | — | — | — | — | |||||||||||||||||||||||
Class A ordinary shares subject to possible redemption |
— | — | — | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance as of December 31, 2021 |
— |
$ |
— |
$ |
$ |
— |
$ |
( |
) |
$ |
( |
) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities: |
||||
Net income |
$ | |||
Adjustments to reconcile net income to net cash used in operating activities: |
||||
Interest earned on cash and Investments held in Trust Account |
( |
) | ||
Offering costs allocated to warrants |
||||
Change in fair value of warrant liabilities |
( |
) | ||
Changes in operating assets and liabilities: |
||||
Prepaid assets |
( |
) | ||
Accounts payable and accrued expenses |
||||
Due to related party |
||||
|
|
|||
Net cash used in operating activities |
( |
) | ||
|
|
|||
Cash Flows from Investing Activities: |
||||
Investment held in Trust Account |
( |
) | ||
|
|
|||
Net cash used in investing activities |
( |
) | ||
|
|
|||
Cash flows from financing activities: |
||||
Proceeds from initial public offering, net of underwriters’ discount |
||||
Proceeds from issuance of Private Placement Warrants |
||||
Proceeds from related party |
||||
Repayment of promissory note—related party |
( |
) | ||
Payments of offering costs |
( |
) | ||
|
|
|||
Net cash provided by financing activities |
||||
|
|
|||
Net change in cash |
||||
Cash, beginning of the period |
||||
|
|
|||
Cash, end of the period |
$ | |||
|
|
|||
Supplemental disclosure of noncash investing and financing activities |
||||
Initial classification of warrant liabilities |
$ | |||
|
|
|||
Initial classification of Class A ordinary shares subject to possible redemption |
$ | |||
|
|
|||
Accretion of Class A ordinary shares to redemption value |
$ | |||
|
|
|||
Deferred underwriting commissions charged to additional paid in capital |
$ | |||
|
|
Gross Proceeds |
$ | |||
Less: |
||||
Proceeds allocated to public warrants |
( |
) | ||
Issuance costs related to Class A common stock |
( |
) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
||||
|
|
|||
Contingently redeemable Class A common stock |
$ |
For the Period from February 8, 2021 (inception) to December 31, 2021 |
||||
Class A ordinary shares subject to possible redemption |
||||
Numerator: |
||||
Net income allocable to Class A ordinary shares subject to possible redemption |
$ | |||
Denominator: |
||||
Weighted Average Redeemable Class A ordinary shares, Basic and Diluted |
||||
|
|
|||
Basic and Diluted net income per share, Redeemable Class A Ordinary shares |
$ | |||
|
|
|||
Class A and Class B non-redeemable ordinary shares |
||||
Numerator: |
||||
Net income allocable to Class B ordinary shares not subject to redemption |
$ | |||
Denominator: |
||||
Weighted Average Non-Redeemable Ordinary shares, Basic and Diluted |
||||
|
|
|||
Basic and diluted net income per share, ordinary shares |
$ | |||
|
|
|||
Level 1 — |
Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment. |
Level 2 — |
Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means. |
Level 3 — |
Valuations based on inputs that are unobservable and significant to the overall fair value measurement. |
• | in whole and not in part; |
• | at a price of $ |
• | upon a minimum of |
• | if, and only if, the last reported sale price (the “closing price”) of the Class A ordinary shares equals or exceeds $ a period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. |
• | in whole and not in part; |
• | at $ |
• | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $ the period ending three trading days before the Company sends the notice of redemption to the warrant holders; and |
• | if the closing price of the Class A ordinary shares for any a period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $ |
December 31, 2021 |
Quoted Priced in Active Markets (Level 1) |
Significant Other Observable Inputs Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
|||||||||||||
Assets: |
||||||||||||||||
U.S. Treasury Securities held in Trust Account |
$ | $ | $ | |
||||||||||||
Liabilities: |
||||||||||||||||
Public warrant liabilities, including over-allotment |
||||||||||||||||
Private warrant liabilities |
||||||||||||||||
Warrant liabilities |
$ | $ | $ | |||||||||||||
April 12, 2021 |
||||||||
December 31, |
(Initial |
|||||||
2021 |
Measurement) |
|||||||
Share price |
$ | $ | ||||||
Strike price |
$ | $ | ||||||
Term (in years) |
||||||||
Volatility |
% | % | ||||||
Risk-free rate |
% | % |
Warrant Liability |
||||
Fair value at December 31, 2020 |
$ | |||
Initial value of public and private warrant liabilities |
||||
Public warrants reclassified to Level 1 |
( |
) | ||
Change in fair value |
( |
) | ||
|
|
|||
Fair Value at December 31, 2021 |
$ | |||
|
|
TIO TECH A | ||||||
(Registrant) | ||||||
Date: March 30 , 2022 |
By: |
/s/ Roman Kirsch | ||||
Roman Kirsch | ||||||
Chief Executive Officer | ||||||
(Principal Executive Officer) |
Name |
Position |
Date | ||
/s/ Dominik Richter |
Chairman, Director |
March 30 , 2022 | ||
Dominik Richter |
||||
/s/ Roman Kirsch |
Chief Executive Officer and Director |
March 30 , 2022 | ||
Roman Kirsch |
(Principal Executive Officer, Director) |
|||
/s/ Jeronimo Folgueira |
Director |
March 30 , 2022 | ||
Jeronimo Folgueira |
||||
/s/ Manuel Stotz |
Director |
March 30 , 2022 | ||
Manuel Stotz |
||||
/s/ Jonathan Teklu |
Director |
March 30 , 2022 | ||
Jonathan Teklu |
||||
/s/ Spyro Korsanos |
Chief Financial Officer |
March 30 , 2022 | ||
Spyro Korsanos |